These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28018110)

  • 1. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
    Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
    Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma.
    Zhuang J; Wang S; Wang Y; Wu Y; Hu R
    BMC Cancer; 2024 May; 24(1):568. PubMed ID: 38714979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Value of Clinical Characteristics and Hematological Parameters for Prognostic Assessment of Pancreatic Cancer Patients Undergoing Radical Resection].
    Zeng L; Li S; Yue P; Yi C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May; 55(3):708-716. PubMed ID: 38948268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of nutrition parameters on short- and long-term outcome in patients with primary resectable pancreatic ductal adenocarcinoma.
    Bareiß S; Merkel S; Krautz C; Weber GF; Grützmann R; Brunner M
    Clin Nutr ESPEN; 2024 Aug; 62():296-302. PubMed ID: 38878292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of Biological and Conditional Factors for Staging of Patients with Resectable Pancreatic Cancer Undergoing Upfront Resection: A Nationwide Analysis.
    Schouten TJ; van Goor IWJM; Dorland GA; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; Cirkel GA; van Dam RM; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; Liem MSL; van Lienden KP; Los M; de Meijer VE; Patijn GA; Schreinemakers JMJ; Stommel MWJ; van Tienhoven GJ; Verdonk RC; Verkooijen HM; van Santvoort HC; Molenaar IQ; Daamen LA;
    Ann Surg Oncol; 2024 Aug; 31(8):4956-4965. PubMed ID: 38386198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of laminin subunit alpha 3 expression in pancreatic ductal adenocarcinoma with tumor liver metastasis and survival.
    Xing Y; Jing X; Qing G; Jiang Y
    Radiol Oncol; 2024 Jun; 58(2):234-242. PubMed ID: 38452390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.
    Hassid BG; Lucas AL; Salomao M; Weng C; Liu F; Khanna LG; Kumar S; Hwang C; Chabot JA; Frucht H
    Pancreas; 2014 Oct; 43(7):1073-7. PubMed ID: 24987871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability.
    Koti S; Demyan L; Deutsch G; Weiss M
    Ann Surg Oncol; 2024 Jun; 31(6):4031-4041. PubMed ID: 38502293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rim Enhancement and Peripancreatic Fat Stranding in Preoperative MDCT as Predictors for Occult Metastasis in PDAC Patients.
    Bai X; Wu L; Dai J; Wang K; Shi H; Lu Z; Ji G; Yu J; Xu Q
    Acad Radiol; 2023 Dec; 30(12):2954-2961. PubMed ID: 37024338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA19-9 With Two-stage Resection Is Useful for Conversion Surgery in PDAC With Synchronous Oligometastases.
    Inoue K; Mizuma M; Motoi F; Kokumai T; Sato H; Kusaka A; Aoki S; Iseki M; Douchi D; Miura T; Maeda S; Ishida M; Ohtsuka H; Nakagawa K; Kamei T; Unno M
    Anticancer Res; 2023 Nov; 43(11):5223-5234. PubMed ID: 37909951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of preoperative renal insufficiency on postoperative outcomes after pancreatic resection: a single institution experience of 1,061 consecutive patients.
    Squires MH; Mehta VV; Fisher SB; Lad NL; Kooby DA; Sarmiento JM; Cardona K; Russell MC; Staley CA; Maithel SK
    J Am Coll Surg; 2014 Jan; 218(1):92-101. PubMed ID: 24211054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic head resection for carcinoma of the ampulla vateri - better long-term prognosis, but more postoperative complications.
    Kuesters S; Sundheimer J; Wittel UA; Chikhladze S; Fichtner-Feigl S; Biesel EA
    Langenbecks Arch Surg; 2024 Apr; 409(1):129. PubMed ID: 38632147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of preoperative statin medication on long-term outcomes after pancreatoduodenectomy for ductal adenocarcinoma: an international multicentric cross-sectional study.
    Joliat GR; Gaspar-Figueiredo S; Labgaa I; Vrochides D; Perinel J; Adham M; Demartines N; Schäfer M
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17007-17014. PubMed ID: 37740766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the efficacy of different surgical strategies in the treatment of patients with initially resectable gastric cancer liver metastases].
    Li L; Gao YH; Zang L; Xue K; Ke B; Shang L; Tang ZQ; Yu J; Liang YR; He ZR; Zheng HL; Huang H; Xiong JP; He ZY; Li JY; Lu TT; Song QY; Liu SH; Chen YW; Tang Y; Liang H; Qiao Z; Chen L
    Zhonghua Wai Ke Za Zhi; 2024 May; 62(5):370-378. PubMed ID: 38548604
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score-matched analysis.
    Yun WG; Han Y; Lee M; Cho YJ; Jung HS; Kwon W; Jang JY
    J Hepatobiliary Pancreat Sci; 2024 Jan; 31(1):50-60. PubMed ID: 37800313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary report of surgical outcomes after single-stage total pancreatectomy: A 10-year experience.
    Zohar N; Kowal L; Moskal D; Ponzini F; Sun G; Lamm RJ; Williamson J; Nevler A; Lavu H; Maley WR; Yeo CJ; Bowne WB
    J Surg Oncol; 2024 Jun; 129(7):1235-1244. PubMed ID: 38419193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal treatment.
    Jomrich G; Gruber M; Gruber ES; Mühlbacher J; Radosavljevic S; Wilfing L; Winkler D; Prager G; Reiterer C; Kabon B; Haslacher H; Sahora K; Schindl M
    J Visc Surg; 2024 Apr; 161(2):99-105. PubMed ID: 37391288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement-A retrospective study.
    Qian L; Li J; Sun Y; Chai W; Deng X; Wang W; Shen B
    Cancer Med; 2023 Dec; 12(23):21199-21208. PubMed ID: 37933476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.
    Javed AA; Mahmud O; Fatimi AS; Habib A; Grewal M; He J; Wolfgang CL; Besselink MG;
    Ann Surg Oncol; 2024 Jul; 31(7):4673-4687. PubMed ID: 38710910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.